Home j Ministry of Health and Family Welfare j GOI [Internet]. Accessed July 13, 2021. https://www.mohfw.gov.in/.
3.
MunsterVJKoopmansMvan DoremalenNvan RielDde WitE. A novel coronavirus emerging in China—key questions for impact assessment. N Engl J Med. 2020;382:692-694.
4.
MunnZMoolaSRiitanoDLisyK. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 2014;3:123-128.
5.
ChenXChenZAzmanAS, et al. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis. Lancet Glob Health. 2021;9:e598-e609.
6.
BobrovitzNAroraRKCaoC, et al. Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis. PLOS ONE. 2021;16(6):e0252617.
7.
RostamiASepidarkishMLeeflangMMG, et al. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis. Clin Microbiol Infect. 2021;27(3):331-340.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
